Beliën, Jarne http://orcid.org/0000-0001-6731-6649
Swinnen, Stijn http://orcid.org/0000-0003-1028-197X
D’hondt, Robbe http://orcid.org/0000-0001-7843-2178
de Juan, Laia Verdú
Dedoncker, Nina
Matthys, Patrick http://orcid.org/0000-0002-9685-6836
Bauer, Jan http://orcid.org/0000-0001-5802-8047
Vens, Celine http://orcid.org/0000-0003-0983-256X
Moylett, Sinéad
Dubois, Bénédicte http://orcid.org/0000-0003-0604-8702
Article History
Received: 9 November 2023
Accepted: 30 May 2024
First Online: 12 June 2024
Competing interests
: B.D. has received consulting fees from Bristol Myers Squibb, Almirall, Roche, Janssen, Novartis and Sanofi. All other authors declare that they have no competing interests.